GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $30,000 | -53.1% | 88,987 | -35.4% | 0.00% | – |
| Q2 2016 | $64,000 | +255.6% | 137,676 | +918.8% | 0.00% | – |
| Q1 2016 | $18,000 | -79.5% | 13,513 | -77.4% | 0.00% | – |
| Q4 2015 | $88,000 | +23.9% | 59,723 | +32.1% | 0.00% | – |
| Q3 2015 | $71,000 | -16.5% | 45,208 | -9.1% | 0.00% | – |
| Q2 2015 | $85,000 | -1.2% | 49,718 | -20.0% | 0.00% | – |
| Q1 2015 | $86,000 | -72.0% | 62,155 | -69.5% | 0.00% | – |
| Q4 2014 | $307,000 | +103.3% | 203,713 | +176.7% | 0.00% | – |
| Q3 2014 | $151,000 | -20.1% | 73,622 | +19.3% | 0.00% | – |
| Q2 2014 | $189,000 | -82.0% | 61,736 | -85.3% | 0.00% | -100.0% |
| Q1 2014 | $1,050,000 | +180.0% | 419,827 | +455.0% | 0.00% | – |
| Q4 2013 | $375,000 | +47.1% | 75,641 | -32.3% | 0.00% | – |
| Q3 2013 | $255,000 | +171.3% | 111,750 | +163.4% | 0.00% | – |
| Q2 2013 | $94,000 | +44.6% | 42,434 | +37.7% | 0.00% | – |
| Q1 2013 | $65,000 | – | 30,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
| Thomasville National Bank | 95,000 | $195,000 | 0.08% |
| SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
| Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |